Yusuke Takeda
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Renal ROCK Activation and Its Pharmacological Inhibition in Patients With Diabetes.
Journal: Frontiers in pharmacology
Published: July 08, 2021
ROCK2-induced metabolic rewiring in diabetic podocytopathy.
Journal: Communications biology
Published: May 28, 2021
Rho-associated, coiled-coil-containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism.
Journal: Kidney international
Published: October 09, 2020
The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease.
Journal: Frontiers in pharmacology
Published: July 21, 2020
Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease.
Journal: Biomedicines
Published: February 01, 2020
ROCK2 regulates TGF-β-induced expression of CTGF and profibrotic genes via NF-κB and cytoskeleton dynamics in mesangial cells.
Journal: American journal of physiology. Renal physiology
Published: August 01, 2019
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease.
Journal: International journal of molecular sciences
Published: June 10, 2019
ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells.
Journal: International journal of molecular sciences
Published: February 26, 2019
Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.
Journal: International journal of molecular sciences
Published: July 18, 2017
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.
Journal: International journal of molecular sciences
Published: January 30, 2017
Last Updated: 09/26/2026